Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare to Sell RayBiotech Arrays, Kits

NEW YORK (GenomeWeb News) — SeraCare Life Sciences will sell RayBiotech’s full line of arrays and kits through its global network, SeraCare said today.
 
Under the agreement, SeraCare will serve as an agent in selling RayBiotech’s antibody arrays, protein arrays, tissue microarrays, and ELISA and EIA kits.
 
RayBiotech’s arrays target cytokines, chemokines, growth/angiogenic factors, adipokines, soluble receptors, matrix metalloproteases, and their inhibitors.
 
SeraCare CEO Susan Vogt said in a statement that the partnership supports the company’s strategy of “expanding our offering of value-added proteomic tools to life sciences researchers around the world.”

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.